Currently, there are 98.25M common shares owned by the public and among those 93.39M shares have been available to trade.
The company’s stock has a 5-day price change of 10.47% and -62.67% over the past three months. SRPT shares are trading -67.11% year to date (YTD), with the 12-month market performance down to -69.87% lower. It has a 12-month low price of $34.10 and touched a high of $173.25 over the same period. SRPT has an average intraday trading volume of 3.23 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -17.60%, -33.91%, and -62.61% respectively.
Institutional ownership of Sarepta Therapeutics Inc (NASDAQ: SRPT) shares accounts for 90.19% of the company’s 98.25M shares outstanding.
It has a market capitalization of $3.93B and a beta (3y monthly) value of 0.57. The earnings-per-share (ttm) stands at -$2.58. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.13% over the week and 7.32% over the month.
Analysts forecast that Sarepta Therapeutics Inc (SRPT) will achieve an EPS of 1.27 for the current quarter, 1.11 for the next quarter and 7.85 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.19 while analysts give the company a high EPS estimate of -0.19. Comparatively, EPS for the current quarter was 0.44 a year ago. Earnings per share for the fiscal year are expected to decrease by -182.15%, and 489.67% over the next financial year.
Looking at the support for the SRPT, a number of firms have released research notes about the stock. Evercore ISI stated their In-line rating for the stock in a research note on May 08, 2025, with the firm’s price target at $50. Wells Fargo coverage for the Sarepta Therapeutics Inc (SRPT) stock in a research note released on April 11, 2025 offered a Overweight rating with a price target of $115. H.C. Wainwright was of a view on April 02, 2025 that the stock is Neutral, while RBC Capital Mkts gave the stock Sector Perform rating on March 31, 2025, issuing a price target of $161- $87. Deutsche Bank on their part issued Hold rating on February 11, 2025.
